CLINICAL GENITOURINARY CANCER, cilt.19, sa.5, ss.405-416, 2021 (SCI-Expanded, Scopus)
A number of radioactive tracers are currently being actively examined to image prostate-specific membrane antigen positive (PSMA+) tumors, especially in primary and recurrent prostate cancer. We report a first-in-human study of [18F]-BF3-Cy3-ACUPA by determining its safety, biodistribution, radiation dosimetry, and feasibility of tumor detection by preoperative positron emission tomography, as well as intraoperative fluorescence imaging, in patients with PSMA+ tumors.